Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-116,516
Closed -$6.7M 55
2014
Q3
$6.7M Buy
116,516
+6,156
+6% +$377K 1.46% 42
2014
Q2
$7.38M Buy
110,360
+6,128
+6% +$415K 1.73% 38
2014
Q1
$6.96M Buy
104,232
+2,420
+2% +$164K 1.72% 36
2013
Q4
$6.79M Buy
101,812
+4,296
+4% +$279K 1.72% 32
2013
Q3
$6.12M Buy
97,516
+5,800
+6% +$373K 1.71% 35
2013
Q2
$5.73M Buy
+91,716
New +$5.82M 1.81% 34

Other funds holding GSK

First Long Island Investors's GSK Position: Q4 2014 in Review

First Long Island Investors sold out of GSK (GSK) in Q4 2014, closing a stake of 116,516 shares — an estimated $6.7M sold.

First Long Island Investors first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $7.38M in Q2 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • First Long Island Investors reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • First Long Island Investors sold 116,516 GSK shares in Q4 2014, an estimated $6.7M.
  • First Long Island Investors first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • First Long Island Investors's GSK position peaked at $7.38M in Q2 2014.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on First Long Island Investors's 13F filing for Q4 2014, filed 10 Feb 2015.